MedTrace Logo

Treatment of Androgenetic Alopecia in Males

NCT00947505 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2012-07-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 7 Beam model in promoting hair growth in males diagnosed with androgenetic alopecia when treatment is applied as directed.

Conditions

Interventions

DEVICE

HairMax LaserComb 2009, 7 Beam

Device application 3 times week (non-consecutive days), for 26 weeks

DEVICE

HairMax LaserComb

Device application 3 times week (non-consecutive days), for 26 weeks

Sponsors & Collaborators

  • Lexington International, LLC

    lead INDUSTRY

Principal Investigators

  • Michael Jarratt, M.D. · DermaResearch, Inc.

  • Abe Marcadis, M.D. · Palm Beach Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00947505 on ClinicalTrials.gov